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the chance to control temperature 
rises.”
The British government is 
sending Stern on a tour of China, 
India, the US and Australia to set 
out British thinking and press 
home the central thesis of his 
review — that it will cost the 
world far more later if it does not 
spend money now to avert climate 
change.
World emissions of greenhouse 
gases were the equivalent of 
42 bn tonnes of carbon dioxide 
in 2000, the report says. The 
biggest source (24%) is the use 
of fossil fuels to generate energy, 
such as power stations that 
burn coal, oil or gas to produce 
electricity. Energy as a fuel for 
transport (14%), industry (14%) 
and to supply building materials 
(8%) is also a big emitter. So are 
changes in land use which mainly 
means cutting down forests. 
Harvesting timber from tropical 
rain forests and using the land 
for oil palm and soya can boost 
income per hectare from $2 to 
$2,000. Stern says: “The loss 
of natural forests around the 
world contributes more to global 
emissions each year than the 
transport sector.”
Stern highlights the likelihood 
of changes in the water cycle as 
one of the earliest outcomes of 
climate change. Droughts and 
floods will become more severe in 
many areas, he argues. Rain will 
increase at higher latitudes and 
decrease in the dry subtropics. 
Hotter land drives more powerful 
evaporation, which brings more 
intense rainfall and flash floods, 
he says.
“Warming may introduce 
sudden shifts in regional weather 
patterns such as the monsoon 
rains in South Asia or the El Niño 
phenomenon”, he says.
Warming over the past 40 years 
has driven species an average of 
four miles towards the poles per 
decade, while seasonal events 
such as flowering have come 
forward several days, he says.
Stern spent more than a year 
examining this problem. His 
report has a simple message: 
climate change is fundamentally 
altering the planet; the risks of 
inaction are high and time is 
running out.American elections rarely turn on 
issues of science. Climate change 
flies far below the popular political 
radar. Americans don’t care that 
much about the space program 
(unless they happen to live in 
Houston or near Cape Canaveral, 
Florida). So it was a bit of a 
surprise that the issue of using 
embryonic stem cells ended up 
providing an important nudge in 
some of the tightest political races 
this fall.
Candidates in close races 
usually tend to shy away from 
divisive issues, such as abortion 
and stem cell research. And as 
of mid-October, it seemed that 
would be the case with stem 
cells. Missouri had a ballot 
proposition that would bolster the 
use of embryonic stem cells for 
research. But, as the New York 
Times noted, Senate candidates 
Jim Talent (the Republican 
incumbent) and Claire McCaskill 
(the Democratic challenger) were 
doing their best to dodge the 
issue.
“Just a few months ago, the 
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was a defining issue of the 
campaign, as both candidates 
tried to firm up support among 
the party faithful in one of the 
tightest Senate races in the 
country,” The Times noted on 
15 October. “But now, as  
Mr. Talent and Ms. McCaskill 
reach beyond their traditional 
bases, the emotionally charged 
ballot measure — which would 
allow the research and possibly 
provide state financing for it — is 
almost too hot to touch.”
That observation turned out 
to be off the mark. Less than 
two weeks later, McCaskill’s 
campaign made a huge splash 
by airing a commercial by actor 
Michael J. Fox, 45, who has 
Parkinson’s disease. “What you 
do in Missouri matters to millions 
of Americans — Americans like 
me,’’ the actor, best known for 
his role in the Back To The Future 
movies, said in a commercial that 
aired during the World Series 
baseball championship. 
As the Daily Telegraph noted, 
“The issue of stem cell research 
is deeply divisive in America. 
Conservative politicians face 
a delicate balancing act when 
considering the demands of 
voters, particularly older citizens, 
and the concerns of religious 
groups over stem cell research.”
Response to this ad was 
swift — and blundered. 
Conservative talk-show host Rush Challenged: President Bush now faces Democrat control in both the House and the 
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The year 2006 might go down in 
history as the time when concern 
about global warming finally 
reached the political mainstream. 
Throughout the industrialized 
world, politicians of all colours 
have acknowledged the problem 
and expressed good intentions 
to do something about it, even if 
many of them are not quite ready 
to give up their ambitions to build 
new airport runways as yet. 
Therefore, it seems fitting 
that the DBU (Deutsche 
Bundesstiftung Umwelt — Federal 
Foundation for the Environment) 
has rewarded a biogeochemist 
who has spent decades 
investigating the role of forests in 
climate change. 
The foundation, which was 
set up in 1991, handed out the 
German Environment Award for 
the 14th time this year. Worth 
500,000 Euros, it is the largest 
such prize in Europe. Previous 
winners include film-maker Heinz 
Sielmann, who died earlier this 
year, and Paul Crutzen, who 
unraveled the mechanisms of 
ozone loss in the stratosphere. 
This year, the award was shared 
equally between biogeochemist 
Europe’s largest environmental 
award recognizes research into 
the role of deforestation in global 
warming, as Michael Gross 
reports.
Prize issues
Carbon concerns: Detlef Schulze shares 
a major European environment award.Limbaugh said Fox’s spasms on 
camera were merely “an act”.
As USA Today put it, “Limbaugh 
noted that Fox, a longtime 
advocate for research on 
embryonic stem cells, has said 
he sometimes does not take his 
medication in order to illustrate 
Parkinson’s severe physical 
effects. Uncontrolled shaking 
and stiffness are among the 
symptoms of the nerve disease.” 
The paper noted that stem cells 
are an issue in at least 20 House, 
Senate and governor races. “Fox’s 
dramatic ads are very effective 
with suburban voters, seniors and 
parents,” the paper said, referring 
to the comments of Evan Tracey 
of the non-partisan Campaign 
Media Analysis Group. “It puts the 
Republicans on the wrong side of 
hope.”
Limbaugh quickly had to 
backpedal and apologize to the 
popular actor for his callous 
comment. But this exchange 
quickly blew up into a national 
issue. Fox ended up providing 
support to other Democrats 
in close races. That included 
Democrat Benjamin Cardin, 
running for US Senate in 
Maryland. Cardin’s opponent, 
Republican Michael Steele, tried 
to counteract the commercials 
with a rebuttal from his sister, 
a physician. The Washington 
Post says she called the ad 
“tasteless”.
“Putting her hand to her 
heart — as Fox does in Cardin’s 
commercial — she then reveals 
her credentials: She has multiple 
sclerosis, and ‘I know he cares 
about me’.”
Fox, campaigning in Ohio 
for Democratic senate-hopeful 
Sherrod Brown, told the Dayton 
Daily News, “As you may know, 
this last week I had a little run-in 
with a less-than compassionate 
conservative. I guess I’m not 
supposed to speak until my 
symptoms go away. Or maybe I’m 
just supposed to go away. But I’m 
not going to go away.”
Indeed, he didn’t go away. 
And neither did most of the 
candidates he supported. 
Sherrod Brown won the US 
Senate seat he sought. So did 
Benjamin Cardin in Maryland. 
The stem-cell research measure passed in Missouri. And 
Democrat Claire McCaskill 
won a razor-thin victory in that 
state, helping Democrats secure 
control of the US Senate. (Not 
everyone Fox backed was 
victorious. Democrat Tammy 
Duckworth, a disabled Iraq war 
veteran in Illinois, lost her bid 
for a seat in the US House of 
Representatives.)
Stem cells never rose to the top 
of the heap in most voters’ minds. 
Exit polls showed that most of 
the Democratic tidal wave was 
the result of dissatisfaction 
with President George W. Bush. 
Americans deeply oppose the 
war in Iraq. They perceived 
Democrats as better able to deal 
with the domestic economy. 
As the BBC put it the day after 
the election, “The Democrats’ 
success has been due in no small 
part to their ability to appeal to 
voters on issues that matter to 
them at home, and a perception 
that the Republican Congress 
has been ineffective and scandal-
ridden.” Yet stem cells could well 
have helped McCaskill squeeze 
out a few desperately needed 
votes to oust incumbent Jim 
Talent.
“Some political analysts say 
his half-hearted rejection of the 
[stem-cell ballot] measure helped 
Ms. McCaskill,” the New York 
Times reported. “Independent and 
undecided voters make up a tiny 
sliver of the state’s electorate, 
and they were largely the focus of 
Mr. Talent’s and Ms. McCaskill’s 
campaigns, as each crossed over 
into the other’s traditional base to 
find an advantage, however small, 
with upbeat appeals and personal 
attacks.”
This election is of course 
not the last word on stem cell 
politics. Assuming Democrats 
in congress are able to craft 
new legislation to expand 
this research, they still face a 
formidable obstacle. The man 
occupying the White House still 
opposes most of this work, and 
he has the power of the veto.
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